CryoPort (CYRX) Moves 26.7% Higher: Will This Strength Last?

CryoPort expects revenues to improve as the year goes on. Revenues from the company's Life Sciences Products group are likely to drive growth. Moreover, it seems that investors are bullish on the fact that the Schall Law Firm, a national shareholder rights litigation firm, is investigating claims regarding violations of the securities laws by CYRX. This development might have led to the northward movement of the CYRX stock following losses over the past few weeks. The stock currently carries a Zacks Rank #2 ...